Andrew Gengos
Andrew Gengos's purchase track record
Andrew Gengos has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/2/2023 | LONA | $243K | -24.8% | -50.0% | +7.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
LeonaBio appears among health‑care stocks moving intraday. LeonaBio was listed among twelve health‑care stocks that showed notable price movement on Monday and again on Friday, according to Benzinga. The mentions suggest the stock experienced intraday volatility during those sessions. With the RSI currently low and the price near a recent support level, the recent activity aligns with a broader sector‑wide movement.
Transaction History
| TTRX | ▲ Buy | Grant | 10,000 | $0 | 10/8/2025 | View on chart |
| LONA | ▼ Sell | Open Market | 1,272 | $720 | 9/5/2024 | View on chart |
| LONA | ▲ Buy | Grant | 5,000 | $0 | 9/3/2024 | View on chart |
| LONA | ▲ Buy | Grant | 10,000 | $13K | 5/20/2024 | View on chart |
| LONA | ▲ Buy | Open Market | 422 | $1K | 6/7/2023 | View on chart |
| LONA | ▲ Buy | Open Market | 2,859 | $10K | 6/7/2023 | View on chart |
| LONA | ▲ Buy | Open Market | 11,719 | $40K | 6/7/2023 | View on chart |
| LONA | ▲ Buy | Open Market | 10,000 | $30K | 6/5/2023 | View on chart |
| LONA | ▲ Buy | Open Market | 10,000 | $30K | 6/5/2023 | View on chart |
| LONA | ▲ Buy | Open Market | 10,000 | $30K | 6/5/2023 | View on chart |
| LONA | ▲ Buy | Open Market | 15,000 | $45K | 6/5/2023 | View on chart |
| LONA | ▲ Buy | Open Market | 10,012 | $28K | 6/2/2023 | View on chart |
| LONA | ▲ Buy | Open Market | 6,582 | $19K | 6/2/2023 | View on chart |
| LONA | ▲ Buy | Open Market | 3,418 | $10K | 6/2/2023 | View on chart |
| LONA | ▼ Sell | Open Market | 1,208 | $4K | 1/5/2023 | View on chart |
| LONA | ▲ Buy | Grant | 5,000 | $0 | 1/4/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Lucid Capital initiates coverage on TTRX with $24 target
Lucid Capital Markets has begun tracking Turn Therapeutics, assigning a Buy rating and setting a price target of $24. This new analyst note adds to the current average target of $25. The stock is currently trading well below its 52-week high, providing context for the new coverage initiation.
Lucid Capital initiates coverage on TTRX with $24 target. Lucid Capital Markets has begun tracking Turn Therapeutics, assigning a Buy rating and setting a price target of $24. This new analyst note adds to the current average target of $25. The stock is currently trading well below its 52-week high, providing context for the new coverage initiation.